Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: a network meta-analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Pharmacological research"
DOI: 10.1016/j.phrs.2020.105020
Abstract: Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are a new class of oral medicines being developed for the treatment of anemia in chronic kidney disease (CKD) patients. This study aimed to compare the efficacy and safety… read more here.
Keywords: epoetin darbepoetin; hif; undergoing dialysis; epoetin ... See more keywords
Nephrologists’ perspectives on the impact of COVID-19 on caring for patients undergoing dialysis in Latin America: a qualitative study
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-062321
Abstract: Objective To describe the experiences of nephrologists on caring for patients undergoing in-centre haemodialysis during the COVID-19 pandemic in Latin America. Design Twenty-five semistructured interviews were conducted by Zoom videoconference in English and Spanish languages… read more here.
Keywords: undergoing dialysis; caring patients; patients undergoing; latin america ... See more keywords
Safety and Efficacy of Imeglimin for Type 2 Diabetes in Patients Undergoing Dialysis
Sign Up to like & getrecommendations! Published in 2023 at "In Vivo"
DOI: 10.21873/invivo.13214
Abstract: Background/Aim: Imeglimin is a novel small molecular tetrahydrotriazine that has been shown to improve hyperglycemia in clinical trials among patients with type 2 diabetes. Nevertheless, its pharmacokinetics in patients with renal dysfunction remain unclear. The… read more here.
Keywords: patients type; safety; diabetes undergoing; undergoing dialysis ... See more keywords